Eric Senneville

29PUBLICATIONS
51CO-AUTHORS
Medical infection agents (incl. prions)Orthodontics and dentofacial orthopaedicsMedical microbiology not elsewhere classifiedOral implantologyPodiatry
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (29)

|Feb 13, 2026
Real-world drug monitoring of dalbavancin using a three-dose regimen of 1500 mg at days 1, 15 and 43 in bone and joint or cardiovascular infection.

Thomas Lin, Eric Senneville, Benjamin Hennart

|Apr 29, 2025
Real-Life Cefiderocol Use in Bone and Joint Infection: A French National Cohort.

Ava Diarra, Maxime Degrendel, Isabelle Eberl

|Mar 17, 2025
Not All in Vein: Oral Antibiotics for Diabetic Foot Osteomyelitis: A Narrative Review.

Benoit Gachet, Marcos C Schechter, David G Armstrong

|Jan 08, 2025
National Cohort of Compassionate Use of Meropenem-Vaborbactam: No Benefit over Meropenem for Pseudomonas aeruginosa.

Aurélien Dinh, Alexandre Bleibtreu, Clara Duran

Pageof 5